Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection

• Published in: Nature communications 2024-02, Vol.15 (1), p.1716-1716, Article 1716
• Main Authors: Lam, Ivan Chun Hang, Zhang, Ran, Man, Kenneth Keng Cheung, Wong, Carlos King Ho, Chui, Celine Sze Ling, Lai, Francisco Tsz Tsun, Li, Xue, Chan, Esther Wai Yin, Lau, Chak Sing, Wong, Ian Chi Kei, Wan, Eric Yuk Fai
• Format: Article
• Language: English
• Subjects: 631/326/596/4130; 692/308/174; 692/699/255; 692/700/459; Cardiovascular diseases; Cohort analysis; Cohort Studies; Complications; COVID-19; COVID-19 - epidemiology; COVID-19 - prevention & control; COVID-19 vaccines; COVID-19 Vaccines - adverse effects; Disease Progression; Drug dosages; Health risks; Humanities and Social Sciences; Humans; Immunization; Infections; Mortality; multidisciplinary; Patients; Retrospective Studies; Risk management; SARS-CoV-2; Science; Science (multidisciplinary); Severe acute respiratory syndrome coronavirus 2; Vaccination; Vaccines
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-024-45953-1

The persisting risk of long-term health consequences of SARS-CoV-2 infection and the protection against such risk conferred by COVID-19 vaccination remains unclear. Here we conducted a retrospective territory-wide cohort study on 1,175,277 patients with SARS-CoV-2 infection stratified by their vaccination status and non-infected controls to evaluate the risk of clinical sequelae, cardiovascular and all-cause mortality using a territory-wide public healthcare database with population-based vaccination records in Hong Kong. A progressive reduction in risk of all-cause mortality was observed over one year between patients with SARS-CoV-2 infection and controls. Patients with complete vaccination or have received booster dose incurred a lower risk of health consequences including major cardiovascular diseases, and all-cause mortality than unvaccinated or patients with incomplete vaccination 30-90 days after infection. Completely vaccinated and patients with booster dose of vaccines did not incur significant higher risk of health consequences from 271 and 91 days of infection onwards, respectively, whilst un-vaccinated and incompletely vaccinated patients continued to incur a greater risk of clinical sequelae for up to a year following SARS-CoV-2 infection. This study provided real-world evidence supporting the effectiveness of COVID-19 vaccines in reducing the risk of long-term health consequences of SARS-CoV-2 infection and its persistence following infection. The long-term health consequences of COVID-19 infection are not fully understood. In this retrospective cohort study from Hong Kong, the authors describe changes in the risk of various clinical outcomes including all-cause mortality for one year following COVID-19 infection and how they vary by vaccination status.